Xponential Fitness, Inc. (XPOF) stands out as a leading global franchisor of boutique health and wellness brands, such as Club Pilates, StretchLab, YogaSix, Pure Barre, and BFT. The company's business model centers on franchise royalties, fees, and equipment sales or leases to studio operators, which generates revenue without the burden of direct operational costs from owning studios. In the competitive leisure and fitness industry, XPOF maintains a strong position as the largest U.S. Pilates franchisor and among the top barre and yoga franchisors by studio count. This asset-light approach offers scalability, but it also leaves the company exposed to franchisee performance, regulatory scrutiny, and shifts in consumer demand—elements that have played a significant role in recent stock movements during post-pandemic recovery and economic pressures on discretionary spending.
In the last 30 days, XPOF stock climbed +26%, moving from about $6.03 to $7.58, reflecting a trend-driven recovery with gains picking up steam in early April. The action was volatile but directional, as shares broke out from a $5.50-$6.30 range on higher volume.
Looking back over the past quarter, however, shares dropped -9%, sliding from roughly $8.31 to $7.58. This period featured steep declines after earnings, followed by consolidation near the lows before the recent upswing, highlighting broader headwinds partially countered by emerging positives.
From what I see, the main driver was XPOF's April 6 announcement that its board has started a formal review of strategic alternatives, which could include a sale, merger, or other transactions, with advice from Jefferies LLC. This came on the heels of pressure from activist investor Kanen Wealth Management on April 1, pushing for a sale and sparking speculation that lifted shares more than 20% in the days that followed. I also checked this using Tickeron’s AI Screener to gauge how the stock stacks up against peers, and analyst moves like Roth/MKM raising its price target further bolstered sentiment. The March 18 resolution of the FTC settlement removed a notable overhang, while improving fitness sector demand provided tailwinds. Together, these shifted views from cautious to optimistic, powering the surge.
The -9% quarterly drop traced back to the February 26 earnings release, where Q4 2025 revenue came in flat at $83 million—beating estimates—but adjusted EPS posted a loss of -$0.91, far missing the expected -$0.03. Full-year 2025 revenue fell 2%, and 2026 guidance looked conservative at $260-270 million in revenue. Shares cratered nearly 50% from $8.05 to $4.26 on the miss and FTC news. A March 19 downgrade from Raymond James to Market Perform, pointing to Club Pilates softness, piled on the pressure. Broader issues like inflation curbing consumer fitness spending, plus franchisee litigation and regulatory hurdles, added weight. Institutional selling and a shift away from cyclicals exacerbated the slide, though things stabilized ahead of April's rally.
In my own research and trading, I often turn to Tickeron’s Trending AI Robots to identify top performers among hundreds of AI trading bots that scan and trade thousands of tickers across markets. These bots use varied strategies—like trend-following, mean reversion, or momentum—across short-term, swing, or long-term horizons, with clear metrics on win rates, profit factors, and drawdowns. Updated live based on fresh results and market relevance, the page spotlights those thriving in today's conditions, giving practical insights into automated trading. I find it valuable for sharpening analysis and spotting opportunities beyond manual reviews.
One thing that stands out is the need to track the strategic alternatives review closely, including any bids or results. Q1 2026 earnings, likely around May 7, will offer clarity on revenue guidance, adjusted EBITDA, and net studio growth. I'm watching franchisee metrics, particularly for Club Pilates, as portfolio tweaks continue. Broader trends in consumer spending, interest rates, and fitness demand recovery will matter too. Regulatory wrap-ups, M&A possibilities, analyst updates, and shifts in institutional ownership could move the needle, while risks like more earnings shortfalls or a drawn-out process linger.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
XPOF moved above its 50-day moving average on June 11, 2026 date and that indicates a change from a downward trend to an upward trend. In of 27 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 10, 2026. You may want to consider a long position or call options on XPOF as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for XPOF just turned positive on May 22, 2026. Looking at past instances where XPOF's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for XPOF crossed bullishly above the 50-day moving average on June 18, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XPOF advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 185 cases where XPOF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for XPOF moved out of overbought territory on June 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XPOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
XPOF broke above its upper Bollinger Band on June 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XPOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (3.893). P/E Ratio (26.609) is within average values for comparable stocks, (53.367). XPOF's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.215). XPOF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (0.789) is also within normal values, averaging (4.369).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XPOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry RecreationalProducts